CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 27,350
-550 (-1.97%)
At close: Aug 4, 2025, 3:30 PM KST
Elevation Oncology Market Cap
CellBion has a market cap or net worth of 350.52 billion as of August 4, 2025.
Market Cap
350.52B
Enterprise Value
323.33B
Revenue
2.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
$27,350.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 350.52B, an increase of 33.25%. That is a compound annual growth rate of 43.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 350.52B | 132.06% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 450.15T |
| SK hynix | 178.11T |
| LG Energy Solution | 87.28T |
| Samsung Biologics | 73.59T |
| Hanwha Aerospace | 48.31T |
| Hyundai Motor Company | 45.86T |
| HD Hyundai Heavy Industries | 42.30T |
| Doosan Enerbility | 39.32T |